Nuvectis Pharma Stock Quote NVCT - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

4.87

Bid

4.87

Ask

5.23

Volume

45,635

4.68 Day's Range 5.0097

4.60 52 Week Range 12.10

Market Cap

94.093M

Previous Close

4.76

Open

4.82

Last Trade

4.87

Last Trade Time

Financial Volume

$ 219,888

VWAP

4.8184

Average Volume (3m)

177,933

Shares Outstanding

19,320,973

Dividend Yield

PE Ratio

-4.27

Earnings Per Share (EPS)

-1.15

Revenue

Net Profit

-22.26M

Nuvectis Pharma Inc is a biopharmaceutical company. Nuvectis Pharma Inc is a biopharmaceutical company.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.nuvectis.com

Headquarters

Wilmington, Delaware, USA

Founded

Nuvectis Pharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NVCT. The last closing price for Nuvectis Pharma was $4.76. Over the last year, Nuvectis Pharma shares have traded in a share price range of $ 4.60 to $ 12.10.

Nuvectis Pharma currently has 19,320,973 shares outstanding. The market capitalization of Nuvectis Pharma is $91.97 million. Nuvectis Pharma has a price to earnings ratio (PE ratio) of -4.27.

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update

Nuvectis Pharma (NASDAQ: NVCT) continues to make strides in precision oncology, gaining momentum following presentations last week at the AACR-NCI-EORTC Symposium where its drug candidate NXP900...

PESG Releases Report on Nuvectis Pharma: With Summit Therapeutics Threatening to Dethrone Merck's Keytruda, Nuvectis' NXP900 is One to Watch

With its focus on targeting well-defined subgroups by inhibiting SRC/YES1 kinases in Non Small-Cell Lung Cancer patients resistant to EGFR and ALK targeted therapies, Nuvectis Pharma’s NXP900...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.39	-7.4144486692	5.26	5.365	4.6	83536	4.87109433	CS
4	-3.5629	-42.2499970354	8.4329	11.8	4.6	271835	6.72672612	CS
12	-1.7	-25.8751902588	6.57	11.8	4.6	177933	7.00571584	CS
26	-1.19	-19.6369636964	6.06	11.8	4.6	132222	6.87281584	CS
52	-3.71	-43.2400932401	8.58	12.1	4.6	113251	7.32851975	CS
156	0.92	23.2911392405	3.95	20.92	3.08	191570	7.85511105	CS
260	0.92	23.2911392405	3.95	20.92	3.08	191570	7.85511105	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
UPCUniverse Pharmaceuticals Inc	$ 3.38 (221.90%)	93.72M
LIFWMSP Recovery Inc	$ 3.2461 (104.16%)	29.08M
GXAIGaxos ai Inc	$ 2.5801 (81.70%)	146.21M
SBETSharpLink Gaming Inc	$ 0.9116 (73.97%)	27.09M
HCTIHealthcare Triangle Inc	$ 1.165 (68.38%)	4.34M
ORISOriental Rise Holdings Ltd	$ 3.6833 (-93.42%)	27.51M
LICNLichen China Limited	$ 0.4895 (-76.91%)	185.96M
MYNAMynaric AG	$ 0.499246 (-64.59%)	3.6M
CEROCERo Therapeutics Holdings Inc	$ 0.1146 (-40.16%)	37.87M
BTCTBTC Digital Ltd	$ 10.50 (-32.95%)	3.26M
SMXSMX Security Matters Public Company	$ 0.4879 (64.06%)	440.04M
SOUNSoundHound AI Inc	$ 15.01 (12.60%)	215.93M
LICNLichen China Limited	$ 0.4895 (-76.91%)	185.96M
NVDANVIDIA Corporation	$ 142.44 (-1.81%)	185.41M
SVMHSRIVARU Holding Ltd	$ 0.0293 (-16.29%)	160.45M